The U.S. Department of Agriculture (USDA) recently issued a temporary delay regarding enforcement on two provisions of its hemp regulations (1).
On February 20, 2020, the Kentucky House of Representatives succeeded in passing legislation that legalized medical marijuana. In the week prior, the Judiciary Committee voted on the bill with a vote of 65–30 in favor.
The U.S. Department of Agriculture (USDA) announced two crop insurance programs on February 6, 2020, which are meant to provide assistance for hemp producers’ crops in regard to natural disasters (1).
On Tuesday, December 3, 2019, Brazil’s pharmaceutical regulator Avinsa approved regulations for the roll-out of medicinal cannabis-based products.
November 20, 2019 marked a monumental day in the prohibition of cannabis. The House Judiciary Committee (1) approved a bill that would federally decriminalize cannabis by removing it from the Controlled Substance Act and expunge particular crimes related to marijuana.
The U.S. Secretary of Agriculture, Sonny Perdue, announced the establishment of the U.S. Domestic Hemp Production Program on October 29, 2019.
A number of causes of hemp testing insanity are documented such as different states using different THC measures to determine legality, lack of representative sampling, and more.
According to a press release from the National Cannabis Industry Association (NCIA), a standalone cannabis policy reform bill was brought before the House of Representatives for a vote on Wednesday, September 25, 2019 and passed with an overwhelming bipartisan majority.
The U.S. Drug Enforcement Administration (DEA) announced in a press release (1) that it is moving forward to facilitate and expand scientific and medical research for cannabis in the United States.
Here we take a closer look at Australia’s medical cannabis program, the laws surrounding it, and speak to Australian pharmacist Paul Mavor.